Ligand validation:7BVJ

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 7BVJ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7BVJ_NAD_B_401	59%	6%	0.098	0.948	3.3	1.86	16	9	1	0	61%	0.6136
7BVJ_NAD_A_401	55%	15%	0.105	0.942	1.9	2.05	4	12	0	0	61%	0.6136
7BVJ_NAD_C_401	49%	14%	0.113	0.929	1.99	2.04	6	9	0	0	61%	0.6136
7BVJ_NAD_D_401	48%	12%	0.116	0.93	1.95	2.32	3	11	0	0	61%	0.6136
7BVK_NAD_B_401	48%	9%	0.13	0.943	2.26	2.45	5	11	1	0	61%	0.6136
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.